ALB and non-small cell lung carcinoma: To systematically describe the role of these albumin-associated inflammatory markers in predicting the prognosis of NSCLC, this review synthesized the published clinical evidence on albumin-associated inflammatory markers in patients with NSCLC, reviewed their applications and cut-off values, and summarized their advantages and disadvantages.